4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000009
EVP, Head of North America sold 75,834 shares at $117.38 ($8,901,531)
- EVP, Head of North America acquired 56,601 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lee Jennifer Kayden EVP, Head of North America | 2026-08-13 | Option exercise 10b5-1 | +35,000 | $24.29 | $850,150 | 54,233 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2026-08-13 | Option exercise 10b5-1 | +21,601 | $6.80 | $146,887 | 75,834 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2026-08-13 | Sale 10b5-1 | −75,834 | $117.38 | $8,901,531 | 0 | D |
| Derivatives | |||||||
| Lee Jennifer Kayden EVP, Head of North America | 2026-08-13 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −35,000 | 36,283 | D | ||
| Lee Jennifer Kayden EVP, Head of North America | 2026-08-13 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −21,601 | 0 | D | ||
| Open-market sales · 75,834 sh · avg $117.38 · $8,901,531 | |||||||
Loading xslF345X06/form4.xml…